Trial Details

COMPLETED
Basic Information
Clinical ID c1115
Identifier NCT01863771
Trial Title A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis.
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Colitis, Ulcerative
Interventions DRUG: Golimumab|OTHER: Placebo
Participant Information
Sponsor Janssen Pharmaceutical K.K.
City Abiko
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2013-03-15
Primary Completion Date 2016-01-29
Completion Date 2016-01-29